Drug details

Fluarix Quadrivalent 2018-2019 (influenza vaccine)

type of Vaccines, Inactivated, Viral

Fluarix Quadrivalent (Influenza Vaccine) 2018-2019 Formula is a vaccine indicated for active immunization for the prevention of disease caused by influenza A subtype viruses and type B viruses contained in the vaccine. Fluarix Quadrivalent is approved for use in persons aged 6 months and older.

This drug may have the following side effects:

• loss of appetite,
• fever
• joint pain,
• muscle aches,
• headache,
• fatigue,
• drowsiness,
• irritability,
• local injection site reactions (pain, redness, swelling),
• gastrointestinal symptoms (nausea, vomiting, diarrhea, or abdominal pain),
• shivering, and

The following drugs are related to Fluarix Quadrivalent 2018-2019, either as a replacement or used together:

• Afluria (influenza virus vaccine)
• Agriflu (influenza virus vaccine for intramuscular injection)
• Xofluza (baloxavir marboxil)
• Vaxelis (diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus, haemophilus b conjugate [meningococcal protein conjugate] and hepatitis b [recombinant] vaccine)
• Fluad (influenza virus vaccine, surface antigen, inactivated, adjuvanted with mf59c.1)
• Fluarix (influenza virus vaccine)
• Flublok (influenza vaccine for intramuscular injection)
• Flublok Quadrivalent 2018-2019 (influenza vaccine)
• Flucelvax (influenza virus vaccine for injection)
• Flucelvax Quadrivalent 2018-2019 Formula (influenza vaccine)
• FluMist 2018-2019 Formula (influenza vaccine intranasal)